...
首页> 外文期刊>American Journal of Physiology >N-glycosylation is essential for ileal ASBT function and protection against proteases
【24h】

N-glycosylation is essential for ileal ASBT function and protection against proteases

机译:N-糖基化对于髂骨ASBT函数和免受蛋白酶的保护至关重要

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The bile acid transporter ASBT is a glycoprotein responsible for active absorption of bile acids. Inhibiting ASBT function and bile acid absorption is an attractive approach to lower plasma cholesterol and improve glucose imbalance in diabetic patients. Deglycosylation of ASBT was shown to decrease its function. However, the exact roles of jV-glycosylation of ASBT, and how it affects its function, is not known. Current studies investigated the roles of Af-glycosylation in ASBT protein stability and protection against proteases utilizing HEK-293 cells stably transfected with ASBT-V5 fusion protein. ASBT-V5 protein was detected as two bands with molecular mass of —41 and —35 kDa. Inhibition of glycosylation by tunicamycin significantly decreased ASBT activity and shifted ASBT bands to —30 kDa, representing a deglycosylated protein. Treatment of total cellular lysates with PNGase F or Endo H glycosidases showed that the upper 41-kDa band represents a fully mature iV-acetylglucosamine-rich glycoprotein and the lower 35-kDa band represents a mannose-rich core glycoprotein. Studies with the glycosylation deficient ASBT mutant (N10Q) showed that the Af-glycosylation is not essential for ASBT targeting to plasma membrane. However, mature glycosylation significantly increased the half-life and protected ASBT protein from digestion with trypsin. Incubating the cells with high glucose (25 mM) for 48 h increased mature glycosylated ASBT along with an increase in its function. These results unravel novel roles for iV-glycosylation of ASBT and suggest that high levels of glucose alter the composition of the glycan and may contribute to the increase in ASBT function in diabetes mellitus.
机译:胆汁酸转运蛋白ASBT是一种糖蛋白,其负责用于活性吸收胆汁酸。抑制ASBT功能和胆汁酸吸收是一种吸引血浆胆固醇的吸引力,并改善糖尿病患者的葡萄糖不平衡。显示ASBT的脱糖基化可降低其功能。但是,ASBT的JV-糖基化的确切作用以及它如何影响其功能,是未知的。目前的研究研究了AF-糖基化在ASBT蛋白稳定性和保护免受诸如ASBT-V5融合蛋白的HEK-293细胞的蛋白酶保护中的作用。检测到ASBT-V5蛋白为2个带分子量的-41和-35kDa的条带。抑制糖基化的叔霉素显着降低了ASBT活性和转移到-30kDA的ASBT带,代表脱糖基化蛋白。用PNGASE F或endoH糖苷酶处理总细胞裂解物的处理表明,上41-KDA带表示完全成熟的IV-乙酰葡糖胺 - 富含富含糖蛋白的富含甘油蛋白,下部35-KDA带代表富含甘露糖的核糖蛋白。糖基化缺陷型ASBT突变体(N10Q)的研究表明,AF-糖基化对于ASBT靶向质膜不是必需的。然而,成熟的糖基化显着增加了从胰蛋白酶消化的半衰期和受到保护的ASBT蛋白。将具有高葡萄糖(25mm)的细胞温育48小时,增加了成熟的糖基化的ASBT以及其功能的增加。这些结果对ASBT的IV-糖基化进行了解开了新的作用,并表明高水平的葡萄糖改变了聚糖的组成,并可能有助于糖尿病患者的ASBT功能的增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号